Securian Asset Management Inc. Sells 200 Shares of Teleflex Incorporated (NYSE:TFX)

Securian Asset Management Inc. lessened its holdings in Teleflex Incorporated (NYSE:TFX) by 7.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,398 shares of the medical technology company’s stock after selling 200 shares during the quarter. Securian Asset Management Inc.’s holdings in Teleflex were worth $427,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the business. Janus Henderson Group PLC increased its position in Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after acquiring an additional 147,147 shares during the period. State Street Corp grew its stake in shares of Teleflex by 1.0% in the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after purchasing an additional 21,291 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Teleflex by 0.5% in the third quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock worth $278,676,000 after purchasing an additional 5,746 shares during the last quarter. Cooke & Bieler LP increased its holdings in Teleflex by 22.1% in the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after purchasing an additional 195,150 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its position in Teleflex by 0.4% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock worth $105,749,000 after purchasing an additional 1,884 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

TFX has been the topic of a number of analyst reports. StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Morgan Stanley reduced their target price on Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday, March 5th. Wells Fargo & Company lowered their price target on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Finally, Piper Sandler reissued a “neutral” rating and set a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $182.63.

Teleflex Trading Up 1.4 %

TFX opened at $139.60 on Tuesday. The company has a market cap of $6.47 billion, a P/E ratio of 27.75, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The company has a fifty day moving average price of $166.18 and a two-hundred day moving average price of $196.64. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1-year low of $128.55 and a 1-year high of $249.91.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 0.97%. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.